Literature DB >> 16880356

Mild cognitive impairment should be considered for DSM-V.

Ronald C Petersen1, John O'Brien.   

Abstract

Mild cognitive impairment is a topic of great activity from both clinical and research perspectives. It represents a transitional state between the cognitive changes of aging and the earliest clinical manifestations of dementia. We present a case for its inclusion in the Diagnostic and Statistical Manual of Mental Disorders (5th ed; DSM-V) based on clinical, outcome, epidemiological, neuroimaging, and pathophysiological data. The strongest case for inclusion can be made for the amnestic subtype, which is likely a clinical precursor of Alzheimer's disease. Arguments are presented as to why mild cognitive impairment can be considered as an entity distinct from normal aging and from clinically probable Alzheimer's disease and why it deserves consideration as a separate construct. In many respects, mild cognitive impairment fulfills criteria for inclusion more adequately than many other conditions currently codified in DSM-IV. Future research directions to help clarify some of the remaining uncertainties are proposed.

Entities:  

Mesh:

Year:  2006        PMID: 16880356     DOI: 10.1177/0891988706291085

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  17 in total

Review 1.  Alzheimer's disease: implications of the updated diagnostic and research criteria.

Authors:  Eric M Reiman; Guy M McKhann; Marilyn S Albert; Reisa A Sperling; Ronald C Petersen; Deborah Blacker
Journal:  J Clin Psychiatry       Date:  2011-09       Impact factor: 4.384

Review 2.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

Review 3.  Challenges in clinical research on Alzheimer's disease: Leon Thal's legacy.

Authors:  Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2007-12-21       Impact factor: 21.566

4.  Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members.

Authors:  J S Roberts; J H Karlawish; W R Uhlmann; R C Petersen; R C Green
Journal:  Neurology       Date:  2010-08-03       Impact factor: 9.910

5.  Anticholinergic Burden and Functional Status in Older People with Cognitive Impairment: Results from the Regal Project.

Authors:  V Boccardi; M Baroni; L Paolacci; S Ercolani; A Longo; M Giordano; C Ruggiero; P Mecocci
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

Review 6.  Mild cognitive impairment: ten years later.

Authors:  Ronald C Petersen; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Yonas E Geda; Robert J Ivnik; Glenn E Smith; Clifford R Jack
Journal:  Arch Neurol       Date:  2009-12

7.  Comparison of 18F-FDG and PiB PET in cognitive impairment.

Authors:  Val J Lowe; Bradley J Kemp; Clifford R Jack; Matthew Senjem; Stephen Weigand; Maria Shiung; Glenn Smith; David Knopman; Bradley Boeve; Brian Mullan; Ronald C Petersen
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

8.  The prevention and treatment of cognitive decline and dementia: An overview of recent research on experimental treatments.

Authors:  Chittaranjan Andrade; Rajiv Radhakrishnan
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

9.  Coexisting Frailty, Cognitive Impairment, and Heart Failure: Implications for Clinical Care.

Authors:  Brittany Butts; Rebecca Gary
Journal:  J Clin Outcomes Manag       Date:  2015-01

10.  Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND).

Authors:  Blossom Cm Stephan; Fiona E Matthews; Kay-Tee Khaw; Carole Dufouil; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.